Trinseo Plc

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: IE0000QBK8U7
USD
0.70
-0.06 (-8.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Trinseo Plc stock-summary
stock-summary
Trinseo Plc
Specialty Chemicals
Trinseo S.A. is a materials company engaged in the manufacture and marketing of synthetic rubber, latex and plastics. The Company's segments include Latex Binders, Synthetic Rubber, Performance Plastics, Basic Plastics, Feedstocks and Americas Styrenics. The Latex Binders segment produces styrene-butadiene latex (SB latex) and other latex polymers and binders. The Synthetic Rubber segment produces synthetic rubber products used in tires, impact modifiers and technical rubber products. The Performance Plastics segment produces compounds and blends and specialized acrylonitrile-butadiene-styrene (ABS) grades. The Basic Plastics segment produces styrenic polymers, including polystyrene, basic ABS, and styrene-acrylonitrile (SAN) products, as well as polycarbonate (PC). The Feedstocks segment includes its production and procurement of styrene monomer outside of North America. The Americas Styrenics segment consists of the operations of its joint venture, Americas Styrenics LLC.
Company Coordinates stock-summary
Company Details
1000 Chesterbrook Boulevard, Suite 3000 , BERWYN PA : 19312
stock-summary
Tel: 1 610 24032001 610 2403221
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 46 Schemes (37.95%)

Foreign Institutions

Held by 77 Foreign Institutions (29.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Frank Bozich
President, Chief Executive Officer, Director
Ms. Jeanmarie Desmond
Director
Mr. Matthew Farrell
Director
Mr. Joseph Alvarado
Independent Director
Mr. Jeffrey Cote
Independent Director
Mr. Pierre-Marie De Leener
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
784 Million
(Quarterly Results - Jun 2025)
Net Profit:
-106 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 110 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

64.46%

stock-summary
Debt Equity

-3.15

stock-summary
Return on Equity

43.14%

stock-summary
Price to Book

-0.15